These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 33595618)
1. An Evaluation of the Performance of Current Morphea Subtype Classifications. Prasad S; Zhu JL; Schollaert-Fitch K; Torok KS; Jacobe HT JAMA Dermatol; 2021 Apr; 157(4):1-8. PubMed ID: 33595618 [TBL] [Abstract][Full Text] [Related]
2. Changes in Disease Activity and Damage Over Time in Patients With Morphea. O'Brien JC; Nymeyer H; Green A; Jacobe HT JAMA Dermatol; 2020 May; 156(5):513-520. PubMed ID: 32236501 [TBL] [Abstract][Full Text] [Related]
3. Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort. Kim A; Marinkovich N; Vasquez R; Jacobe HT J Rheumatol; 2014 Jan; 41(1):106-12. PubMed ID: 24293577 [TBL] [Abstract][Full Text] [Related]
4. Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort. Condie D; Grabell D; Jacobe H Arthritis Rheumatol; 2014 Dec; 66(12):3496-504. PubMed ID: 25156342 [TBL] [Abstract][Full Text] [Related]
5. Linear morphea: Clinical characteristics, disease course, and treatment of the Morphea in Adults and Children cohort. Kunzler E; Florez-Pollack S; Teske N; O'Brien J; Prasad S; Jacobe H J Am Acad Dermatol; 2019 Jun; 80(6):1664-1670.e1. PubMed ID: 31005342 [TBL] [Abstract][Full Text] [Related]
7. Morphea disease activity during pregnancy: A case series. Walker AM; Bermas BL; Jacobe HT J Dermatol; 2022 Dec; 49(12):1278-1283. PubMed ID: 36093764 [TBL] [Abstract][Full Text] [Related]
8. Skin mapping for the classification of generalized morphea. Teske N; Welser J; Jacobe H J Am Acad Dermatol; 2018 Feb; 78(2):351-357. PubMed ID: 29332706 [TBL] [Abstract][Full Text] [Related]
9. Morphea in adults and children cohort III: nested case-control study--the clinical significance of autoantibodies in morphea. Dharamsi JW; Victor S; Aguwa N; Ahn C; Arnett F; Mayes MD; Jacobe H JAMA Dermatol; 2013 Oct; 149(10):1159-65. PubMed ID: 23925398 [TBL] [Abstract][Full Text] [Related]
10. Correlates of self-reported quality of life in adults and children with morphea. Das S; Bernstein I; Jacobe H J Am Acad Dermatol; 2014 May; 70(5):904-10. PubMed ID: 24534655 [TBL] [Abstract][Full Text] [Related]
11. Development and Validation of the Morphea Activity Measure in Patients With Pediatric Morphea. García-Romero MT; Tollefson M; Pope E; Brandling-Bennett HA; Paller AS; Keimig E; Arkin L; Wanat KA; Humphrey SR; Werth VP; Oza V; Jacobe H; Fett N; Cordoro KM; Medina-Vera I; Chiu YE JAMA Dermatol; 2023 Mar; 159(3):299-307. PubMed ID: 36753150 [TBL] [Abstract][Full Text] [Related]
12. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Zulian F; Athreya BH; Laxer R; Nelson AM; Feitosa de Oliveira SK; Punaro MG; Cuttica R; Higgins GC; Van Suijlekom-Smit LW; Moore TL; Lindsley C; Garcia-Consuegra J; Esteves Hilário MO; Lepore L; Silva CA; Machado C; Garay SM; Uziel Y; Martini G; Foeldvari I; Peserico A; Woo P; Harper J; Rheumatology (Oxford); 2006 May; 45(5):614-20. PubMed ID: 16368732 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea. Arthur M; Fett NM; Latour E; Jacobe H; Kunzler E; Florez-Pollack S; Houser J; Sharma S; Prasad S; Femia A; Stern MJ; Pappas-Taffer LK; Gaffney R; Fernandez AP; Knabel D; Cardones AR; Leung N; Laumann A; Yu JM; Zhao J; Vleugels RA; Tkachenko E; Lo K JAMA Dermatol; 2020 May; 156(5):521-528. PubMed ID: 32236497 [TBL] [Abstract][Full Text] [Related]
14. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Leitenberger JJ; Cayce RL; Haley RW; Adams-Huet B; Bergstresser PR; Jacobe HT Arch Dermatol; 2009 May; 145(5):545-50. PubMed ID: 19451498 [TBL] [Abstract][Full Text] [Related]
15. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. Peterson LS; Nelson AM; Su WP; Mason T; O'Fallon WM; Gabriel SE J Rheumatol; 1997 Jan; 24(1):73-80. PubMed ID: 9002014 [TBL] [Abstract][Full Text] [Related]
16. Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment. Johnson W; Jacobe H J Am Acad Dermatol; 2012 Nov; 67(5):881-9. PubMed ID: 22382198 [TBL] [Abstract][Full Text] [Related]
17. Morphea patients with mucocutaneous involvement: A cross-sectional study from the Morphea in Adults and Children (MAC) cohort. Prasad S; Black SM; Zhu JL; Sharma S; Jacobe H J Am Acad Dermatol; 2021 Jul; 85(1):114-120. PubMed ID: 33249064 [TBL] [Abstract][Full Text] [Related]
18. Classification of morphea (localized scleroderma). Peterson LS; Nelson AM; Su WP Mayo Clin Proc; 1995 Nov; 70(11):1068-76. PubMed ID: 7475336 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory arthritis in pediatric patients with morphea. Kashem SW; Correll CK; Vehe RK; Hobday PM; Binstadt BA; Maguiness SM J Am Acad Dermatol; 2018 Jul; 79(1):47-51.e2. PubMed ID: 29535035 [TBL] [Abstract][Full Text] [Related]
20. Body site distribution of pediatric-onset morphea and association with extracutaneous manifestations. Chiu YE; Shmuylovich L; Kiguradze T; Anderson K; Sibbald C; Tollefson M; Kunzler E; Tom WL; Bond K; Ahmad RC; Garcia-Romero MT; Irfan M; Kollman K; Hunt R; Stein SL; Arkin L; Wong V; Pope E; Jacobe H; Brandling-Bennett HA; Cordoro KM; Bercovitch L; Rangel SM; Liu X; Szabo A; Paller AS J Am Acad Dermatol; 2021 Jul; 85(1):38-45. PubMed ID: 33689776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]